Pages that link to "Q43246326"

The following pages link to Understanding the relationship between baseline BMI and subsequent weight change in antipsychotic trials: effect modification or regression to the mean? (Q43246326):

Displaying 23 items.

• Management of antipsychotic-related weight gain (Q24610124) (← links)
• Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians (Q34033259) (← links)
• Weight-gain in psychiatric treatment: risks, implications, and strategies for prevention and management (Q34543946) (← links)
• Weight change by baseline BMI from three-year observational data: findings from the Worldwide Schizophrenia Outpatient Health Outcomes Database (Q34560134) (← links)
• Antipsychotic drugs and obesity (Q34648940) (← links)
• Assessing regression to the mean effects in health care initiatives (Q35001066) (← links)
• Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profiles (Q35577365) (← links)
• Ignoring regression to the mean leads to unsupported conclusion about obesity (Q35595052) (← links)
• Anthropometric characteristics and the burden of altered nutritional status among neuropsychiatric patients at Zomba Mental Hospital in Zomba, Malawi (Q36034675) (← links)
• Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs (Q36063735) (← links)
• Common scientific and statistical errors in obesity research. (Q36755588) (← links)
• Improving metabolic parameters of antipsychotic child treatment (IMPACT) study: rationale, design, and methods (Q37354917) (← links)
• Weight considerations in psychotropic drug prescribing and switching (Q38151453) (← links)
• Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management (Q38504254) (← links)
• Change in daytime sleepiness and cognitive function in a 6-month, double-blind study of lurasidone and quetiapine XR in patients with schizophrenia (Q41040144) (← links)
• Investigation of molecular serum profiles associated with predisposition to antipsychotic-induced weight gain (Q47213104) (← links)
• Obesity and weight-related medical problems of incarcerated persons with and without mental disorders (Q47311231) (← links)
• Regression to the mean, apparent data errors, and biologically extraordinary results: Letter regarding 'Changes in telomere length 3-5 years after gastric bypass surgery'. (Q47327097) (← links)
• Changes in metabolic parameters in patients with severe mental illness over a 10-year period: A retrospective cohort study (Q50546113) (← links)
• Deterioration of metabolic parameters during short-term psychiatric inpatient treatment: a prospective naturalistic study (Q50778364) (← links)
• Unaccounted for regression to the mean renders conclusion of article titled "Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor tofogliflozin" unsubstantiated (Q88372443) (← links)
• Best (but oft-forgotten) practices: identifying and accounting for regression to the mean in nutrition and obesity research (Q90268663) (← links)
• Letter to the editor (Q94408597) (← links)